1. Home
  2. RPM vs MRNA Comparison

RPM vs MRNA Comparison

Compare RPM & MRNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RPM
  • MRNA
  • Stock Information
  • Founded
  • RPM 1947
  • MRNA 2010
  • Country
  • RPM United States
  • MRNA United States
  • Employees
  • RPM N/A
  • MRNA N/A
  • Industry
  • RPM Paints/Coatings
  • MRNA Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • RPM Consumer Discretionary
  • MRNA Health Care
  • Exchange
  • RPM Nasdaq
  • MRNA Nasdaq
  • Market Cap
  • RPM 13.6B
  • MRNA 16.0B
  • IPO Year
  • RPM N/A
  • MRNA 2018
  • Fundamental
  • Price
  • RPM $104.48
  • MRNA $27.22
  • Analyst Decision
  • RPM Buy
  • MRNA Hold
  • Analyst Count
  • RPM 11
  • MRNA 20
  • Target Price
  • RPM $123.18
  • MRNA $54.47
  • AVG Volume (30 Days)
  • RPM 826.9K
  • MRNA 9.8M
  • Earning Date
  • RPM 04-08-2025
  • MRNA 05-01-2025
  • Dividend Yield
  • RPM 1.95%
  • MRNA N/A
  • EPS Growth
  • RPM 15.12
  • MRNA N/A
  • EPS
  • RPM 4.99
  • MRNA N/A
  • Revenue
  • RPM $7,298,832,000.00
  • MRNA $3,236,000,000.00
  • Revenue This Year
  • RPM $0.54
  • MRNA N/A
  • Revenue Next Year
  • RPM $3.43
  • MRNA $22.07
  • P/E Ratio
  • RPM $20.91
  • MRNA N/A
  • Revenue Growth
  • RPM N/A
  • MRNA N/A
  • 52 Week Low
  • RPM $95.28
  • MRNA $23.15
  • 52 Week High
  • RPM $141.79
  • MRNA $170.47
  • Technical
  • Relative Strength Index (RSI)
  • RPM 42.63
  • MRNA 47.01
  • Support Level
  • RPM $103.00
  • MRNA $26.33
  • Resistance Level
  • RPM $108.59
  • MRNA $27.88
  • Average True Range (ATR)
  • RPM 4.49
  • MRNA 1.84
  • MACD
  • RPM 0.41
  • MRNA 0.43
  • Stochastic Oscillator
  • RPM 61.66
  • MRNA 86.05

About RPM RPM International Inc.

RPM International Inc manufactures and sells a variety of paints, coatings, and adhesives. The firm organizes itself into four segments based on product type. The construction products group sells coatings, roofing, insulation, and other products to distributors, contractors, and end consumers globally. The performance coatings group produces coatings that are used in construction and industrial applications like floorings and corrosion control. The consumer group sells paint, finishes, and similar products to individual consumers through hardware and craft stores. The specialty products group sells a line of products ranging from niche applications of the other groups to marine finishes, to edible food colorings. The majority of revenue comes from North America.

About MRNA Moderna Inc.

Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its covid vaccine, which was authorized in the United States in December 2020. Moderna had 40 mRNA development candidates in clinical development as of September 2024. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.

Share on Social Networks: